Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Myriad Genetics: Starting to Outperform
Seeking Alpha
Wednesday, December 30, 2009 - 1:39pm
tags:
Myriad Genetics
Drug stocks slip; Compugen rallies on stock sale
Marketwatch
Wednesday, December 30, 2009 - 1:38pm
tags:
drug stocks, CompuGen
It's Time for Adventrx to Follow Through on NDA
Seeking Alpha
Wednesday, December 30, 2009 - 9:50am
tags:
NDA, Adventrx
Valeant Pharmaceuticals' Retigabine Accepted For FDA Review
WSJ Online
Wednesday, December 30, 2009 - 9:35am
tags:
Valeant Pharmaceuticals, FDA, retigabine, epilepsy
Is the FDA Too Easy On Medical Devices?
WSJ Online
Wednesday, December 30, 2009 - 9:33am
tags:
FDA, medical devices
5-Star Stocks Poised to Pop: Repligen
Motley Fool
Wednesday, December 30, 2009 - 9:31am
tags:
Repligen
Basilea plunges on FDA rejection of J&J drug trials
Marketwatch
Wednesday, December 30, 2009 - 9:30am
tags:
FDA, JNJ, Basilea, ceftobiprole
Ranbaxy offloads Chinese venture stake
Fierce Pharma
Wednesday, December 30, 2009 - 9:29am
tags:
Ranbaxy, China
Senate Health Care Bill Shows Sky Is Not Falling On Drug Makers
BNET Pharma
Wednesday, December 30, 2009 - 9:22am
tags:
healthcare reform, healthcare bill
Novartis May Sell Bonds in 2010 for $28.2 Billion Alcon Deal
Bloomberg
Wednesday, December 30, 2009 - 9:21am
tags:
Alcon, Novartis, bonds, M&A
Pfizer Stops Cancer Trial as Survival Didn’t Improve
Bloomberg
Wednesday, December 30, 2009 - 9:19am
tags:
Pfizer, drug trials, lung cancer, figitumumab
AstraZeneca Strengthens Pipeline
Yahoo/Zacks.com
Wednesday, December 30, 2009 - 9:18am
tags:
AstraZeneca, Forest Labs, Novexel, M&A
Santarus eyes Phase III trials for diarrhea drug
Marketwatch
Wednesday, December 30, 2009 - 9:17am
tags:
diarrhea, Santarus
Novo Nordisk awaiting FDA comment on diabetes drug
Marketwatch
Wednesday, December 30, 2009 - 9:16am
tags:
Novo Nordisk, FDA, diabetes, liraglutide
Cephalon Sees Bullish Options Move
TheStreet.com
Wednesday, December 30, 2009 - 9:16am
tags:
Cephalon
Isis Gains from Teva-OncoGenex Deal
Yahoo/Zacks.com
Wednesday, December 30, 2009 - 9:15am
tags:
Isis Pharmaceuticals, partnerships, Teva Pharmaceuticals, OncoGenex
Drugmaker Hikma has unique model to compete
FT.com
Wednesday, December 30, 2009 - 9:13am
tags:
Hikma, generics, patents
AstraZeneca: FDA Backs Crestor’s Wider Use
Seeking Alpha
Tuesday, December 29, 2009 - 10:08am
tags:
AstraZeneca, FDA, Crestor
The Sanofi-Chattem Deal: What Insider Trading Looks Like
BNET Pharma
Tuesday, December 29, 2009 - 10:06am
tags:
Sanofi, M&A, insider trading, Chattem
Drug stocks inch higher; Trimeris slides
Marketwatch
Tuesday, December 29, 2009 - 9:53am
tags:
drug stocks, Trimeris

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.